Onconetix News

Blue Water Biotech Analyst Ratings

BenzingaSep 13, 2023 11:59 ET

HC Wainwright Adjusts Price Target on Blue Water Biotech to $9 From $7, Maintains Buy Rating

MT NewswiresApr 26, 2023 11:29 ET

HC Wainwright & Co. Maintains Buy on Blue Water Biotech, Raises Price Target to $9

BenzingaApr 26, 2023 10:37 ET

Maxim Group Remains a Buy on Blue Water Vaccines, Inc. (BWV)

TipRanksApr 21, 2023 11:07 ET

Maxim Group Keeps Their Buy Rating on Blue Water Vaccines, Inc. (BWV)

TipRanksFeb 2, 2023 14:40 ET

Blue Water Vaccines Analyst Ratings

Benzinga Analyst RatingsFeb 1, 2023 12:13 ET

HC Wainwright & Co. Reiterates Buy on Blue Water Vaccines, Maintains $7 Price Target

Benzinga Real-time NewsFeb 1, 2023 12:12 ET

Blue Water Vaccines, Inc. (BWV) Gets a Buy From H.C. Wainwright

TipRanksFeb 1, 2023 12:10 ET

Blue Water Vaccines Analyst Ratings

Benzinga Analyst RatingsDec 9, 2022 06:12 ET

HC Wainwright & Co. Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $7

Benzinga Real-time NewsDec 9, 2022 06:11 ET

Blue Water Vaccines Analyst Ratings

Benzinga Analyst RatingsDec 8, 2022 08:42 ET

Maxim Group Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $4

Benzinga Real-time NewsDec 8, 2022 08:42 ET